Brind.

Motilal Oswal recommends Indegene and Pearl Global stocks, while Indegene benefits from pharma outsourcing trends and plans capacity scaling.

1 report, 1 independent Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Motilal Oswal recommends Indegene and Pearl Global stocks, while Indegene benefits from pharma outsourcing trends and plans capacity scaling.

Coverage

Newest first; wire copies grouped